US · GDRX
GoodRx Holdings, Inc.
- Sector
- Healthcare · Medical - Healthcare Information Services
- Headquarters
- Santa Monica, CA 90404
- Website
- goodrx.com
Price · as of 2025-12-31
$2.55
Market cap 635.85M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $27.97 | +996.86% |
| Intrinsic Value(DCF) | $1.14 | -55.29% |
| Graham-Dodd Method(GD) | $1.68 | -34.08% |
| Graham Formula(GF) | $2.02 | -20.82% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | $0.00 | $11.37 | |||
| 2020 | $39.05 | $46.55 | $115.43 | $0.00 | $0.00 |
| 2021 | $13.87 | $36.48 | $161.08 | $0.92 | $0.00 |
| 2022 | $5.76 | $29.74 | $4.59 | $0.58 | $0.00 |
| 2023 | $7.39 | $29.68 | $1.02 | $0.75 | $0.00 |
| 2024 | $4.61 | $31.45 | $0.72 | $1.03 | $0.57 |
| 2025 | $2.17 | $27.97 | $0.44 | $1.68 | $2.02 |
AI valuation
Our deep-learning model estimates GoodRx Holdings, Inc.'s (GDRX) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $27.97
- Current price
- $2.55
- AI upside
- +996.86%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$1.14
-55.29% upside
Graham-Dodd
$1.68
-34.08% upside
Graham Formula
$2.02
-20.82% upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| GDRX | GoodRx Holdings, Inc. | $2.55 | 635.85M | +997% | -55% | -34% | -21% | 30.91 | 1.25 | 0.97 | 3.10 | 29.70 | 6.35 | 92.77% | 10.98% | 10.37% | 3.73% | 14.18% | 1.79% | 0.10 | 2.05 | 2.61 | 2.02 | -1.10 | 10407.00% | 57.00% | -3234.00% | 9.94% | 0.55 | 12.45% | 0.00% | 0.00% | 65.21% | 6.53 | 7.43 | 0.72 | 0.29 |
| AHCO | AdaptHealth Corp. | $9.15 | 1.24B | +239% | -53% | — | — | -19.73 | 0.86 | 0.40 | 2.75 | — | -1.18 | 17.52% | 5.74% | -2.18% | -4.27% | 7.18% | -1.50% | 0.12 | 1.76 | 1.02 | 0.67 | 0.16 | -18525.00% | -49.00% | -696.00% | 16.84% | 0.84 | 8.45% | 0.00% | 0.00% | 148.90% | 7.43 | 6.31 | 0.43 | 0.97 |
| AMPH | Amphastar Pharmaceuticals… | $20.23 | 929.61M | +167% | -56% | -25% | -32% | — | 1.25 | 1.36 | 5.01 | — | 4.41 | 49.46% | 19.50% | 13.63% | 0.00% | 13.00% | 0.00% | 0.06 | 5.51 | 4.02 | 2.70 | -0.82 | -3366.00% | -165.00% | -10000.00% | 0.00% | 0.00 | 0.00% | 0.00% | — | 63.32% | 5.32 | — | 1.04 | 2.35 |
| COLL | Collegium Pharmaceutical,… | $41.67 | 1.32B | +93% | +451% | -64% | +46% | 20.98 | 4.37 | 1.69 | 4.41 | — | -2.57 | 59.35% | 23.01% | 8.05% | 23.70% | 14.73% | 3.79% | 2.70 | 2.18 | 1.57 | 1.36 | 1.47 | -699.00% | 2362.00% | 6111.00% | 24.84% | 0.75 | 39.58% | 0.00% | 0.00% | 17.45% | 9.73 | 5.33 | 2.24 | 1.51 |
| CTEV | Claritev Corporation | $13.47 | 222.6M | +1,151% | -57% | — | — | -0.83 | -1.36 | 0.25 | 10.21 | — | -0.05 | 27.61% | 4.67% | -29.45% | 632.60% | 0.76% | -5.66% | -26.64 | 0.11 | 0.86 | 0.59 | 9.71 | -8303.00% | 374.00% | 1685.00% | -5.18% | 0.45 | -0.27% | 0.00% | 0.00% | 0.00% | 107.70 | -395.26 | 5.03 | -0.45 |
| HSTM | HealthStream, Inc. | $21.23 | 629.85M | +76% | -51% | -73% | -65% | 34.97 | 1.81 | 2.11 | 8.98 | — | 8.96 | 64.74% | 6.66% | 6.03% | 5.14% | 5.38% | 3.56% | 0.04 | — | 0.96 | 0.77 | -0.32 | -758.00% | 426.00% | 10203.00% | 9.30% | 0.51 | 20.08% | 0.58% | 20.30% | 5.26% | 29.61 | 10.05 | 1.97 | 3.35 |
| INVA | Innoviva, Inc. | $22.96 | 1.48B | +363% | -42% | +62% | +354% | 5.67 | 1.31 | 3.62 | 2.57 | 0.69 | 1.58 | 72.33% | 38.52% | 63.78% | 29.09% | 20.10% | 18.47% | 0.00 | 9.81 | 14.64 | 11.79 | -1.44 | 81667.00% | 1852.00% | 392.00% | 12.73% | 3.96 | 28.97% | 0.00% | 0.00% | 45.61% | 6.03 | 5.04 | 2.32 | 3.32 |
| IRMD | IRadimed Corporation | $103.53 | 1.32B | -46% | -36% | — | -72% | 33.89 | 7.51 | 8.90 | 26.33 | 305.02 | 7.79 | 76.94% | 29.99% | 26.26% | 24.31% | 59.56% | 20.20% | 0.00 | — | 8.84 | 7.38 | -2.29 | 1111.00% | 1171.00% | 22283.00% | 2.70% | 3.01 | 60.30% | 2.10% | 71.10% | 2.77% | 27.31 | 34.04 | 8.19 | 37.09 |
| LFMD | LifeMD, Inc. | $2.67 | 128.52M | +1,008% | +2,300% | — | — | -10.27 | -35.07 | 0.91 | -27.43 | — | -9.02 | 88.67% | -7.60% | -8.89% | 1891.64% | 123.73% | -28.61% | -4.58 | -7.40 | 0.81 | 0.72 | 1.49 | -2429.00% | 3927.00% | 677408.00% | 3.11% | 0.29 | -45.81% | 1.61% | -16.60% | 1.61% | -11.30 | 30.53 | 0.86 | -1.05 |
| MDXG | MiMedx Group, Inc. | $4.89 | 724.22M | +613% | +792% | -34% | +83% | 14.85 | 2.81 | 1.72 | 6.71 | 103.93 | 3.23 | 82.56% | 15.26% | 11.60% | 21.61% | 45.59% | 16.02% | 0.01 | 35.83 | 4.32 | 3.76 | -1.99 | 1429.00% | 1999.00% | 1311.00% | 10.12% | 1.15 | 71.03% | 0.00% | 0.00% | 12.22% | 8.71 | 7.63 | 1.33 | 7.43 |
| PLSE | Pulse Biosciences, Inc. | $18.73 | 1.27B | — | — | — | — | -17.46 | 15.75 | 3629.72 | -16.69 | -100.37 | 16.44 | -360.00% | -21982.57% | -20794.57% | -74.45% | -1168.13% | -63.68% | 0.09 | — | 10.53 | 10.22 | 1.02 | 1739.00% | — | 4927.00% | -4.29% | -6.83 | -826.49% | 0.00% | 0.00% | 0.00% | -15.56 | -21.99 | 3420.56 | 40.87 |
About GoodRx Holdings, Inc.
GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including subscriptions, pharma manufacturer solutions, and telehealth services. It serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was incorporated in 2015 and is headquartered in Santa Monica, California.
- CEO
- Douglas Joseph Hirsch
- Employees
- 738
- Beta
- 1.50
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($1.14 ÷ $2.55) − 1 = -55.29% (DCF, example).